Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences, Dynomics Partner for Leukemia, Lymphoma Dx Development

NEW YORK, March 29 (GenomeWeb News) - BD Biosciences has partnered with Dutch diagnostics shop Dynomics to develop tests for leukemia and lymphoma, BD said today.


BD now has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion proteins, the company said.


William Rhodes, president of cell analysis at BD Biosciences, said that the partnership will give "BD the opportunity to advance technical solutions that can be applied in [its] core markets of ASR and reagent components used in leukemia and lymphoma testing."


Financial terms were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.